产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
---|---|---|---|---|
A998538 | Anti-CDH11 / Cadherin-11 Reference Antibody (RG6125), Anti-CDH11 / Cadherin-11 Reference Antibody (RG6125), |
|||
A998539 | Anti-CDH3 / P-cadherin Reference Antibody (PF-03732010), Anti-CDH3 / P-cadherin Reference Antibody (PF-03732010), |
|||
A998540 | Anti-CDH6 / K-Cadherin Reference Antibody (DS-6000a), Anti-CDH6 / K-Cadherin Reference Antibody (DS-6000a), |
|||
A998541 | Anti-CDH6 / K-Cadherin Reference Antibody (HKT288), Anti-CDH6 / K-Cadherin Reference Antibody (HKT288), |
|||
A998542 | Anti-Cdiff Toxin A Reference Antibody (actoxumab), Anti-Cdiff Toxin A Reference Antibody (actoxumab), |
|||
A998543 | Anti-CEACAM1 / CD66a Reference Antibody (Chaim Sheba Med. Cntr. patent anti-CEACAM1), Anti-CEACAM1 / CD66a Reference Antibody (Chaim Sheba Med. Cntr. patent anti-CEACAM1), |
|||
A998544 | Anti-CEACAM1 / CD66a Reference Antibody (CM-24), Anti-CEACAM1 / CD66a Reference Antibody (CM-24), |
|||
A998545 | Anti-CEACAM5 / CEA / CD66e Reference Antibody (cergutuzumAb), Anti-CEACAM5 / CEA / CD66e Reference Antibody (cergutuzumAb), |
|||
A998546 | Anti-CEACAM5 / CEA / CD66e Reference Antibody (Immunomedics patent anti-CEACAM5 (Class III)), Anti-CEACAM5 / CEA / CD66e Reference Antibody (Immunomedics patent anti-CEACAM5 (Class III)), |
|||
A998547 | Anti-CEACAM5 / CEA / CD66e Reference Antibody (labetuzumab), Anti-CEACAM5 / CEA / CD66e Reference Antibody (labetuzumab), |
|||
A998548 | Anti-CEACAM5 / CEA / CD66e Reference Antibody (tusamitamab), Anti-CEACAM5 / CEA / CD66e Reference Antibody (tusamitamab), |
|||
A998549 | Anti-CEACAM6 / CD66c Reference Antibody (NEO-201), Anti-CEACAM6 / CD66c Reference Antibody (NEO-201), |
|||
A998550 | Anti-CEACAM6 / CD66c Reference Antibody (tinurilimab), Anti-CEACAM6 / CD66c Reference Antibody (tinurilimab), |
|||
A998551 | Anti-CHI3L1 Reference Antibody (Brown U. patent anti-CHI3L1), Anti-CHI3L1 Reference Antibody (Brown U. patent anti-CHI3L1), |
|||
A998552 | Anti-Clathrin Heavy Chain / CHC Reference Antibody (Academia Sinica patent anti-Clathrin Heavy Chain), Anti-Clathrin Heavy Chain / CHC Reference Antibody (Academia Sinica patent anti-Clathrin Heavy Chain), |
|||
A998553 | Anti-CLDN18.2 Reference Antibody (zolbetuximab), Anti-CLDN18.2 Reference Antibody (zolbetuximab), |
|||
A998554 | Anti-CLEC12A / CD371 Reference Antibody (tepoditamab), Anti-CLEC12A / CD371 Reference Antibody (tepoditamab), |
|||
A998555 | Anti-CLEC14A Reference Antibody (Scripps Korea patent anti-CLEC14A), Anti-CLEC14A Reference Antibody (Scripps Korea patent anti-CLEC14A), |
|||
A998556 | Anti-CLEC4C Reference Antibody (BIIB059), Anti-CLEC4C Reference Antibody (BIIB059), |
|||
A998557 | Anti-CLEC4C Reference Antibody (LFB patent anti-BDCA-2), Anti-CLEC4C Reference Antibody (LFB patent anti-BDCA-2), |